Riyadh – Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) surged by 109.82% for the second quarter (Q2) of 2026, reaching SAR 68.40 million.

The quarterly results were compared to SAR 32.60 million during the same period last year. The company attributed the growth to a 22.98% increase in quarterly revenues, which climbed to SAR 492.90 million.

The revenue growth was supported by a 134.20% jump in international sales, contributing an additional SAR 34.60 million, and a 15.30% rise in private and government sector sales.

Operating profit for the quarter climbed by 44.46% to SAR 88.70 million as the company benefited from higher top-line performance.

For the first half (H1) of 2026, the net profit reached SAR 133.50 million, a 28.99% increase from SAR 103.50 million in the prior-year period.

Half-year revenues grew to SAR 916.70 million, supported by an 85% increase in international segment sales and a 55.90% leap in contract manufacturing.

SPIMACO noted that financing costs fell by 18.60%, or SAR 9.20 million, during the period. Earnings per share (EPS) for H1-26 improved to SAR 1.12, up from SAR 0.87 a year earlier.

In Q1-26, the company’s net profits amounted to SAR 65.10 million, while the revenues totaled SAR 423.80 million.